You have 9 free searches left this month | for more free features.

Condition

Newly Diagnosed FLT3 Mutated AML (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Arog Pharmaceuticals, Inc. (1)

Collaborator

Intervention

crenolanib (1)

cytarabine (1)

duanorubicin (1)

midostaurin (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

duanorubicin

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Newly Diagnosed FLT3 Mutated AML Trial in United States (Crenolanib, Midostaurin, Cytarabine)

Recruiting

Newly Diagnosed FLT3 Mutated AML

Crenolanib
+3 more

Duarte, California
+30 more

May 21, 2020